Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Abroad (travel likely)RecruitingPHASE1
Conditions
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Sanford Oncology Clinic and Pharmacy, Sioux Falls, South Dakota, United States
Sarah Cannon Research Institute Oncology Partners, Nashville, Tennessee, United States
Next Oncology - Dallas, Irving, Texas, United States
Study leads
MD
Study Director
Amgen